An early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests for Chlamydia trachomatis and Neisseria gonorrhoea in genitourinary medicine clinics in England

OBJECTIVES: To estimate the costs and benefits of clinical pathways incorporating a point of care (POC) nucleic acid amplification test (NAAT) for chlamydia and gonorrhoea in genitourinary medicine (GUM) clinics compared with standard off-site laboratory testing. METHOD: We simulated 1.2 million GUM...

Descripción completa

Detalles Bibliográficos
Autores principales: Turner, Katherine M E, Round, Jeff, Horner, Patrick, Macleod, John, Goldenberg, Simon, Deol, Arminder, Adams, Elisabeth J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2013
Materias:
Health Services Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3932743/
https://www.ncbi.nlm.nih.gov/pubmed/24273127
http://dx.doi.org/10.1136/sextrans-2013-051147

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3932743/
https://www.ncbi.nlm.nih.gov/pubmed/24273127
http://dx.doi.org/10.1136/sextrans-2013-051147

Ejemplares similares